1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited

KIMS.BO
Krishna Institute of Medical Sciences LimitedIN flagBombay Stock Exchange
736.20
INR
-10.35
- -
294.58BMarket Cap
Krishna Institute of Medical Sciences Limited
KIMS.BO
(Bombay Stock Exchange)

Recent

price

736.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
22.94
28.06
35.05
41.56
54.17
61.83
75.86
- -
97.37
Revenue per Share
-1.19
2.98
5.37
8.38
8.41
7.75
9.61
- -
6.02
Basic EPS, GAAP
1.41
3.74
6.99
3.87
-3.56
-3.15
-10.67
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-5.45
-4.01
0.35
8.75
15.45
20.02
27.87
- -
1.99
Book Value per Share
11.63
12.51
20.48
32.58
38.79
43
50.3
- -
53.94
Tangible Book Value per Share
400
400
374
397
400
400
400
- -
401
Basic Weighted Avg Shares
9,180
11,226
13,122
16,508
21,677
24,740
30,350
39,046
39,046
Sales/Revenue/Turnover
13.33
16.14
23.54
26.84
22.58
20.31
19.95
13.29
13.29
Operating Margin (%)
565
706
695
727
1,293
1,465
1,772
2,832
2,832
Depreciation Expense
-478
1,192
2,012
3,327
3,363
3,100
3,845
2,414
2,414
Net Income, GAAP
- -
18.11
26.36
24.75
24.56
26.9
25.68
27.52
27.52
Effective Tax Rate (%)
-5.2
10.62
15.33
20.15
15.52
12.53
12.67
6.18
6.18
Profit Margin (%)
-270
10
1,729
1,784
1,812
954
-1,389
-3,015
-3,015
Working Capital
2,882
3,143
2,279
2,263
6,336
12,265
22,872
36,374
36,374
LT Debt
5,669
6,114
8,762
14,106
19,380
20,931
24,188
25,585
25,585
Total Equity
- -
16.27
21.63
23.93
17.66
12.35
10.83
6.41
6.41
Return on Invested Capital (%)
- -
84.67
77.57
68.84
30.01
15.96
13.22
9.02
9.02
Return on Capital (%)
- -
- -
- -
184.48
69.64
43.68
40.13
40.39
40.39
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
5,174
- -
6,155
LT Borrowings
20,170
- -
26,726
LT Finance Leases
6,526
- -
9,648
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
- -
400
Market Capitalization
280,262
243,433
249,653

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
8,233
- -
9,374
Cash, Cash Equivalents & STI
1,744
- -
1,573
Accounts Receivable, Net
4,844
- -
5,542
Inventories
800
- -
969
Total Current Liabilities
11,457
- -
12,389
Payables & Accruals
- -
- -
- -
ST Debt
5,174
- -
6,155
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.55%
5.78%
Free Cash Flow
- -
21.61%
114.73%
Net Income, GAAP
- -
9.08%
-37.22%
Sales/Revenue/Turnover
- -
24.51%
28.65%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,060
6,525
6,058
6,096
24,740
2025
6,884
7,773
7,724
7,969
30,350
2026
8,716
9,607
9,977
10,746
39,046

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.02
2.3
1.8
- -
7.75
2025
2.16
2.68
2.22
2.54
9.61
2026
1.96
1.67
1.33
1.06
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Jack Nathan Medical Corp. (JNH.V)
Town Health International Medical Group Limited (3886.HK)
Mobile-health Network Solutions Class A Ordinary Shares (MNDR)
MLP Saglik Hizmetleri A.S. (MPARK.IS)
Almoosa Health Company (4018.SR)
MD Medical Group Investments Plc (MDMG.L)
Business
Krishna Institute of Medical Sciences Limited (KIMS) operates as a multi-specialty hospital chain providing comprehensive healthcare services across various medical disciplines. The company offers inpatient and outpatient care, including super specialty services such as cardiology, oncology, neurology, nephrology, gastroenterology, orthopedics, critical care, and organ transplants; diagnostic services encompassing pathology, radiology, and imaging; and ancillary offerings like pharmacy, ambulance services, and wellness programs. KIMS serves patients through its network of hospitals primarily in southern India, targeting urban and semi-urban populations with a focus on tertiary care. Founded in 2000 and headquartered in Secunderabad, Telangana, India, the company listed on the Bombay Stock Exchange in December 2021 via IPO and has expanded its footprint with new facilities in Telangana and Andhra Pradesh. Recent developments include the inauguration of a 250-bed hospital in Ongole, Andhra Pradesh in 2023 and a 450-bed advanced facility in Hyderabad's Gachibowli area in 2024, alongside strategic capacity enhancements and technology integrations for specialties like robotic surgery and advanced imaging.